Home › Funds › Kedalion Capital Management LLP › ABUS

Kedalion Capital Management LLP position in ABUS

ARBUTUS BIOPHARMA CORP · Health Care

Kedalion Capital Management LLP reported holding 20,168 shares of ABUS (ARBUTUS BIOPHARMA CORP) in its Q3 2026 13F filing — a position valued at US$96K, representing 0.00% of its reported portfolio and ranking #5 among its reported holdings. Kedalion Capital Management LLP first reported this position in Q3 2026.

Latest position (Q3 2026)20.17K sh
Reported value held$96.40K
Portfolio Weight0.00%
First reportedQ3 2026
Last changeNew
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How Kedalion Capital Management LLP's ABUS position evolved

Kedalion Capital Management LLP first disclosed a stake in ABUS in Q3 2026 at 20,168 shares (US$96K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 20.17K $96.40K New

About ABUS and 13F data

ABUS (ARBUTUS BIOPHARMA CORP) is a Health Care company. 44 other funds we track also report a position in ABUS — the largest reported positions include Whitefort Capital Management, LP (US$75.8M), Two Seas Capital LP (US$38.9M), BlackBarn Capital Partners LP (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABUS

All ABUS fund holders →

FAQ

How long has Kedalion Capital Management LLP held ABUS?

Kedalion Capital Management LLP has disclosed ABUS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Kedalion Capital Management LLP's current position in ABUS?

As of Q3 2026, Kedalion Capital Management LLP holds 20.17K shares of ABUS (ARBUTUS BIOPHARMA CORP), valued at $96.40K, representing 0.00% of its reported portfolio and ranking #5.

Has Kedalion Capital Management LLP been buying or selling ABUS?

In the latest 13F filing (Q3 2026), Kedalion Capital Management LLP newly opened its position in ABUS.

Which other funds hold ABUS?

Other major institutional holders of ABUS include Whitefort Capital Management, LP, Two Seas Capital LP, BlackBarn Capital Partners LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.